• Illumina’s Newest DRAGEN, Lupus Research Alliance Launches Dataset, More

    May 29 | Bio-IT World | Illumina announced the launch of DRAGEN version 4.4 software; Lupus Research Alliance (LRA) announced the launch of the Lupus Nexus Foundational Analyses; and more. More

  • The ALL ALS Consortium’s Open Science Initiative

    May 27 | Bio-IT World | The Access for All in ALS (ALL ALS) Consortium is spearheading an ambitious open science initiative that aims to transform how we understand and treat this devastating neurological disease. Led by Robert Bowser, Ph.D. of the Barrow Neurological Institute and James Berry, M.D. of Massachusetts General Hospital, the consortium is conducting two studies: ASSESS for people living with ALS and healthy controls and PREVENT for those with genetic risk factors but no symptoms. More

  • CURATE.AI: How Digital Twins Are Revolutionizing Precision Dosing

    May 22 | Bio-IT World | Singapore researchers have developed an innovative artificial intelligence platform that creates personalized “digital twins” of patients to optimize drug dosing on an individual basis. The CURATE.AI platform, developed by Dr. Dean Ho and his team at the National University of Singapore's Institute for Digital Medicine (WisDM), represents a significant advancement in precision medicine by dynamically adjusting treatment regimens based on real-time patient responses. More

  • Innovative Practices Winner: Chromatography Data Management

    May 21 | Bio-IT World | Genmab partnered with Genedata to address the challenges of capturing chromatography data. Their effort earned them a 2025 Innovative Practices Awards for their joint development of Chromatics, a new Genedata product developed to meet the needs of chromatography data. In their pursuit of differentiated therapeutic antibodies, Genmab found chromatography data a particularly unwieldy piece of the pipeline. More

  • Regeneron Acquires 23andMe for $256 Million

    May 20 | Bio-IT World | DNA testing company 23andMe was purchased by Regeneron for $256 million. The deal is expected to close on July 1. The deal includes “substantially all assets” of 23and Me, but it will not include Lemonaid Health, a telehealth services provider that 23andMe plans to gradually close. More

  • Trends from the Trenches: Data, Discovery, Politics

    May 15 | Bio-IT World | Ari Berman, CEO of Bio Team, opened the Trends from the Trenches session at the Bio-IT World Conference & Expo by following the data journey from generation to application and outlining the pain points along the way. At the end of his presentation, he got political, challenging the audience to stay engaged in science and the scientific community no matter the political winds. More

  • Sweden's PROMISE Initiative: Bridging Research and Healthcare Through Multi-Omics

    May 14 | Bio-IT World | Sweden is positioning itself at the forefront of precision medicine with an ambitious new initiative that aims to transform how scientific research translates to patient care. The Precision Omics Initiative Sweden (PROMISE), recently outlined in Nature Medicine, seeks to revolutionize healthcare by creating a seamless flow of data between research laboratories and clinical settings. More

  • CFDE Unites Data Enthusiasts During Hackathon before Kick-Off of Bio-IT World Conference

    May 13 | Bio-IT World | Last month, a cohort of 40 participants convened for the Common Fund Data Ecosystem Open Source and FAIR Data Hackathon at the 6th Annual Bio-IT World Hackathon held April 1–2, 2025 in Boston, Mass. Teams tackled a broad range of challenges including linking glycoenzyme expression to disease pathways, enabling cellular-level comparisons using HuBMAP imaging data, and more. More

  • MiLabs Launches Platforma: Bridging the Gap Between Biology and Bioinformatics

    May 08 | Bio-IT World | For many years, Stan Poslavsky applied his Ph.D. in theoretical physics to work in quantum theory. But when he switched to work in immunology, he noticed the need for better computational software for biologists. So he developed a software platform. MiLaboratories began its journey with MiXCR, a software for processing next-generation sequencing data for T-cells and B-cells. More

  • First-of-its-Kind AI Tool Reveals the ‘Social Network’ of Cancer Cells

    May 07 | Bio-IT World | Researchers in Europe have developed a unique deep learning tool for analyzing spatial transcriptomics data to help decipher communication happening cell to cell as well as at the community level within tissues. It’s the first artificial intelligence (AI) method capable of measuring and interpreting a range of data from a cell's “social network." More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!